Maximize the ability to identify molecularly matched therapies​

Driven by targeted molecular therapies and immunotherapies, precision medicine offers an individualized approach that battles cancer at its core—the genome. As new oncogenic drivers are uncovered at an unprecedented rate, a testing method that can keep pace is needed. One method meeting this challenge is comprehensive genomic profiling, or CGP.

Explore this e-book by Illumina to enable precision medicine with comprehensive genomic profiling

 

Fill the form to learn more

By submitting this form, you consent to the collection and sharing of your contact details so we can respond to your inquiry and send relevant updates from illumina, including information on products, services, and events. Your data will be processed in Canada and then securely transferred to illumina, which will manage your information and handle any opt-out or removal requests. For details on how your data is used and protected, please review our Terms of Use and our Privacy,Opt-out and Information Removal policies below.